PharmaCorp Rx(TSXV) PCRX

Market CapCA$78.46MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2022)+233%
5 YearN/A
1 Year-20%
1 Month-10%
CA$0.40
-2.44%
-0.01Today
PharmaCorp Rx last closing stock price
MetricPriceDate
Last closeCAD 0.402026-10-13
PharmaCorp Rx stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-4.76%CAD 0.422026-10-06
1 month-10.11%CAD 0.452026-09-11
3 month-23.08%CAD 0.522026-07-15
Year to date-12.09%CAD 0.462025-12-31
1 year-20%CAD 0.502025-10-10
3 year+90.48%CAD 0.212023-04-19
Since inception+233.33%CAD 0.122022-09-29

PharmaCorp Rx Financials at a Glance

Market Cap

CA$78.46MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

CA$27.41

Net Income (TTM)

-CA$1.04

EPS (TTM)

-CA$0.01

P/E Ratio

-49.38

Dividend

CA$0.00

Beta (Volatility)

-0.05 (Low)

Price

CA$0.40

Volume

50,504

Open

CA$0.41

Previous Close

CA$0.40

Daily Range

CA$0.40 - CA$0.41

52-Week Range

CA$0.39 - CA$0.58

Estimated Earnings Date

Aug 20, 2026

PCRX News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About PharmaCorp Rx

Pharmacorp Rx Inc. is a Canadian pharmacy acquisition and ownership platform dedicated to empowering pharmacists as equity partners. The company supports succession planning for retiring pharmacy owners, enhancing the sustainability of community pharmacies.

Products and Services
  • Acquisition and ownership of community pharmacies
  • Equity partnership programs for pharmacists
  • Succession planning services for retiring pharmacy owners
Growth Outlook
  • Established in 2021, the company is positioned for rapid growth
  • Focus on community pharmacy sustainability aligns with market trends
  • Increasing demand for pharmacy ownership opportunities among pharmacists
Financial Highlights
  • Market capitalization of CAD 84.34 million indicates strong investor interest
  • Stock price range of CAD 0.40 to CAD 0.58 reflects stability
  • Beta of -0.40 suggests lower volatility compared to the overall market
Pharmacorp Rx Inc. operates in the financial services sector, specifically within the pharmacy industry. The company was founded on September 1, 2021, and is headquartered in Saskatoon, Canada. With a focus on empowering pharmacists and ensuring the continuity of community pharmacies, Pharmacorp Rx is strategically positioned to capitalize on the growing demand for pharmacy ownership. The recent market capitalization and stock price stability indicate a solid foundation for potential growth. The company's innovative approach to pharmacy ownership and succession planning is expected to resonate well with both pharmacists and investors alike.
AI Generated • Sep 17, 2026

Industry

Food and Staples Retailing

Sector

Consumer Staples

Employees

5

CEO

Grady Brown

Website

www.pharmacorprx.ca

Headquarters

Saskatoon, SK S7T 0J1, CA

PCRX Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

-2.89%

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

-2.03%

Dividend Yield

0.00%

Payout Ratio

N/A

Stock Overview

Market Cap

CA$78.46MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

196.15M

Volume

50.50K

Avg. Volume

141.25K

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

PharmaCorp Rx Performance Analysis

PharmaCorp Rx annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31CAD 0N/A
20232023-12-31CAD 0N/A
20242024-12-31CAD 5,794,914N/A
20252025-12-31CAD 20,894,507260.6%
PharmaCorp Rx annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31CAD -0.031884.6%
20232023-12-31CAD -0.02-10.1%
20242024-12-31CAD -0.01-46.6%
20252025-12-31CAD -0.01-4.8%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

CA$7.73

+1.8%

Gross Profit

CA$0.94

+2.4%

Gross Margin

12.15%

+1.4%

Market Cap

CA$78.46MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

CA$15.73

N/A

Employees

5

N/A

Net Income

CA$0.12

-0.3%

EBITDA

CA$0.21

-1.5%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

CA$28.44

+172.4%

Total Debt

CA$4.43

+5.0%

Accounts Receivable

CA$1.40

+2.2%

Inventory

CA$3.13

+1.8%

Long Term Debt

CA$3.88

+5.3%

Short Term Debt

CA$0.54

+3.6%

Return on Assets

-2.41%

+2.0%

Return on Invested Capital

-9.65%

+0.8%

Free Cash Flow

CA$0.76

-0.3%

Operating Cash Flow

CA$0.82

-4.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
^GSPCS&P 500
$7,803.85-0.00%
^DJIDJI
$51,687.96-0.00%
^IXICNASDAQ
$27,201.84-0.00%
BTCBitcoin
$83,069.00+0.01%

Trending Stocks

Symbol / CompanyPricePrice Chg
SOXSDirexion Shares ETF Trust - Direxion Daily Semiconductor Bear 3x ETF
$37.42+0.62%
KORUDirexion Shares ETF Trust - Direxion Daily Msci South Korea Bull 3x Shares
$14.72-6.48%
SOXLDirexion Shares ETF Trust - Direxion Daily Semiconductor Bull 3x ETF
$127.57-0.65%
NOKNokia
$9.86-0.40%

Questions About PCRX

What is the current price of PharmaCorp Rx?

PharmaCorp Rx is trading at CA$0.40 per share.

What is the 52-week range for PharmaCorp Rx?

Over the past 52 weeks, PharmaCorp Rx has traded between CA$0.39 and CA$0.58.

How much debt does PharmaCorp Rx have?

As of the most recent reporting period, PharmaCorp Rx reported total debt of CA$4.43M.

How much cash does PharmaCorp Rx have on hand?

PharmaCorp Rx reported CA$24.01M in cash and cash equivalents in its most recent financial results.

What is PharmaCorp Rx’s dividend yield?

PharmaCorp Rx does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services